COVID-19 Conversation: Introduction

In this series of videos from LUNGevity, oncologist Zosia Piotrowska, MD, MHS, Massachusetts General Hospital, Boston, addresses many of the questions and concerns raised in regard to coronavirus COVID-19 and patients with lung cancer.

In this series of videos from LUNGevity, oncologist Zosia Piotrowska, MD, MHS, Massachusetts General Hospital, Boston, addresses many of the questions and concerns raised in regard to coronavirus COVID-19 and patients with lung cancer.

COVID-19 Conversation

Part 1: About Coronavirus – COVID-19

Lung cancer continues to
be the second most common
cancer in the United
States and the leading
cause of cancer-related death
for men and for women. Lung
cancer is often diagnosed in a
later stage, when treatment may
be more challenging than when
the cancer is detected early.

People with cancer often have a compromised immune system, which requires special care during the COVID-19 pandemic. This article offers practical expert advice on taking precautions and using reliable resources.

In the second article of this 4-part series, the authors present an overview of the current treatment landscape for NSCLC, including a description of the most often used treatments and common questions that patients can ask their providers.

Last modified: March 31, 2020

Interested in
receiving the latest
Lung Cancer-related news?

Subscribe below!

E-Newsletters & Communications

I consent to receive communications from CONQUER and agree to the Privacy Policy.